|
1
|
Yakaryilmaz FD and Ozturk ZA: Treatment of
type 2 diabetes mellitus in the elderly. World J Diabetes.
8:278–285. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Koch A, Grammatikos G, Trautmann S,
Schreiber Y, Thomas D, Bruns F, Pfeilschifter J, Badenhoop K and
Penna-Martinez M: Vitamin D supplementation enhances
c18(dihydro)ceramide levels in type 2 diabetes patients. Int J Mol
Sci. 18:E15322017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bilir B, Bilir Ekiz B, Yilmaz I, Atile
Soysal N, Yildirim T, Kara SP, Gumustas SA, Orhan AE and Aydin M:
Association of apelin, endoglin and endocan with diabetic
peripheral neuropathy in type 2 diabetic patients. Eur Rev Med
Pharmacol Sci. 20:892–898. 2016.PubMed/NCBI
|
|
4
|
Peiro C, Lorenzo O, Carraro R and
Sanchez-Ferrer CF: IL-1β inhibition in cardiovascular complications
associated to diabetes mellitus. Front Pharmacol. 8:3632017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dunn JS, Mlynarski WM, Pezzolesi MG,
Borowiec M, Powers C, Krolewski AS and Doria A: Examination of
PPP1R3B as a candidate gene for the type 2 diabetes and MODY loci
on chromosome 8p23. Ann Hum Genet. 70:587–593. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tun NN, Arunagirinathan G, Munshi SK and
Pappachan JM: Diabetes mellitus and stroke: A clinical update.
World J Diabetes. 8:235–248. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shukla SK, Liu W, Sikder K, Addya S,
Sarkar A, Wei Y and Rafiq K: HMGCS2 is a key ketogenic enzyme
potentially involved in type 1 diabetes with high cardiovascular
risk. Sci Rep. 7:45902017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Naqvi S, Naveed S, Ali Z, Ahmad SM, Khan
Asadullah R, Raj H, Shariff S, Rupareliya C, Zahra F and Khan S:
Correlation between glycated hemoglobin and triglyceride level in
type 2 diabetes mellitus. Cureus. 9:e13472017.PubMed/NCBI
|
|
9
|
Kupelian V, Hayes FJ, Link CL, Rosen R and
McKinlay JB: Inverse association of testosterone and the metabolic
syndrome in men is consistent across race and ethnic groups. J Clin
Endocrinol Metab. 93:3403–3410. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Saibandith B, Spencer JPE, Rowland IR and
Commane DM: Olive polyphenols and the metabolic syndrome.
Molecules. 22:E10822017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tatemoto K, Hosoya M, Habata Y, Fujii R,
Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, et
al: Isolation and characterization of a novel endogenous peptide
ligand for the human APJ receptor. Biochem Biophys Res Commun.
251:471–476. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cirillo P, Ziviello F, Pellegrino G, Conte
S, Cimmino G, Giaquinto A, Pacifico F, Leonardi A, Golino P and
Trimarco B: The adipokine apelin-13 induces expression of
prothrombotic tissue factor. Thromb Haemost. 113:363–372. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Folino A, Montarolo PG, Samaja M and
Rastaldo R: Effects of apelin on the cardiovascular system. Heart
Fail Rev. 20:505–518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou Q, Cao J and Chen L: Apelin/APJ
system: A novel therapeutic target for oxidative stress-related
inflammatory diseases (Review). Int J Mol Med. 37:1159–1169. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang S, Chen L, Lu L and Li L: The
apelin-APJ axis: A novel potential therapeutic target for organ
fibrosis. Clin Chim Acta. 456:81–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang YW, He SJ, Feng X, Cheng J, Luo YT,
Tian L and Huang Q: Metformin: A review of its potential
indications. Drug Des Devel Ther. 11:2421–2429. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sena CM, Matafome P, Louro T, Nunes E and
Seica RM: Effects of atorvastatin and insulin in vascular
dysfunction associated with type 2 diabetes. Physiol Res.
63:189–197. 2014.PubMed/NCBI
|
|
18
|
Howarth FC, Qureshi MA, Sobhy ZH, Parekh
K, Yammahi SR, Adrian TE and Adeghate E: Structural lesions and
changing pattern of expression of genes encoding cardiac muscle
proteins are associated with ventricular myocyte dysfunction in
type 2 diabetic goto-kakizaki rats fed a high-fat diet. Exp
Physiol. 96:765–777. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Y, Qi H, Wang Y, Wu M, Cao Y, Huang W,
Li L, Ji Z and Sun H: Allicin protects against myocardial apoptosis
and fibrosis in streptozotocin-induced diabetic rats.
Phytomedicine. 19:693–698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wichi R, Malfitano C, Rosa K, De Souza SB,
Salemi V, Mostarda C, De Angelis K and Irigoyen MC: Noninvasive and
invasive evaluation of cardiac dysfunction in experimental diabetes
in rodents. Cardiovasc Diabetol. 6:142007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun
YC and Ko YL: Triglyceride glucose-body mass index is a simple and
clinically useful surrogate marker for insulin resistance in
nondiabetic individuals. PLoS One. 11:e01497312016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Relimpio F: ‘The relative contributions of
insulin resistance and beta-cell dysfunction to the pathophysiology
of Type 2 diabetes’ by kahn se. Diabetologia. 46:17072003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang Q, Li X, Song P and Xu L: Optimal
cut-off values for the homeostasis model assessment of insulin
resistance (HOMA-IR) and pre-diabetes screening: Developments in
research and prospects for the future. Drug Discov Ther. 9:380–385.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Morimoto A, Tatsumi Y, Soyano F, Miyamatsu
N, Sonoda N, Godai K, Ohno Y, Noda M and Deura K: Increase in
homeostasis model assessment of insulin resistance (HOMA-IR) had a
strong impact on the development of type 2 diabetes in Japanese
individuals with impaired insulin secretion: The Saku study. PLoS
One. 9:e1058272014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu XW, Deng FY and Lei SF: Meta-analysis
of atherogenic index of plasma and other lipid parameters in
relation to risk of type 2 diabetes mellitus. Prim Care Diabetes.
9:60–67. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mooradian AD: Dyslipidemia in type 2
diabetes mellitus. Nat Clin Pract Endocrinol Metab. 5:150–159.
2009.PubMed/NCBI
|
|
27
|
Tian L and Fu M: The relationship between
high density lipoprotein subclass profile and plasma lipids
concentrations. Lipids Health Dis. 9:1182010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tian L, Liu Y, Qin Y, Long S, Xu Y and Fu
M: Association of the low-density lipoprotein
cholesterol/high-density lipoprotein cholesterol ratio and
concentrations of plasma lipids with high-density lipoprotein
subclass distribution in the Chinese population. Lipids Health Dis.
9:692010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong WT, Wong SL, Tian XY and Huang Y:
Endothelial dysfunction: The common consequence in diabetes and
hypertension. J Cardiovasc Pharmacol. 55:300–307. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsumoto T, Lopes RA, Taguchi K,
Kobayashi T and Tostes RC: Linking the beneficial effects of
current therapeutic approaches in diabetes to the vascular
endothelin system. Life Sci. 118:129–135. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kalani M: The importance of endothelin-1
for microvascular dysfunction in diabetes. Vasc Health Risk Manag.
4:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Finch J and Conklin DJ: Air
pollution-induced vascular dysfunction: Potential role of
endothelin-1 (ET-1) system. Cardiovasc Toxicol. 16:260–275. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ergul A: Endothelin-1 and diabetic
complications: Focus on the vasculature. Pharmacol Res. 63:477–482.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kaneko Kurohane Y and Ishikawa T: Dual
role of nitric oxide in pancreatic β-cells. J Pharmacol Sci.
123:295–300. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xie W and Du L: Diabetes is an
inflammatory disease: Evidence from traditional chinese medicines.
Diabetes Obes Metab. 13:289–301. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ziamajidi N, Nasiri A, Abbasalipourkabir R
and Moheb Sadeghi S: Effects of garlic extract on TNF-α expression
and oxidative stress status in the kidneys of rats with STZ +
nicotinamide-induced diabetes. Pharm Biol. 55:526–531. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao L, Sun T and Wang L: Chitosan
oligosaccharide improves the therapeutic efficacy of sitagliptin
for the therapy of chinese elderly patients with type 2 diabetes
mellitus. Ther Clin Risk Manag. 13:739–750. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu Y, Wang X, Zhao Y, Zhao P, Wang L,
Zhai Q, Zhang X, Tian W, Xiang X and Li T: Upregulation of tumor
necrosis factor-α-induced protein 8-like 2 mrna is negatively
correlated with serum concentrations of tumor necrosis factor-α and
interleukin 6 in type 2 diabetes mellitus. J Diabetes Res.
2017:48023192017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y, Proenca R, Maffei M, Barone M,
Leopold L and Friedman JM: Positional cloning of the mouse obese
gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hosoi T and Ozawa K: Possible
pharmacological approach targeting endoplasmic reticulum stress to
ameliorate leptin resistance in obesity. Front Endocrinol
(Lausanne). 7:592016.PubMed/NCBI
|
|
41
|
Jacobo-Cejudo MG, Valdes-Ramos R,
Guadarrama-Lopez AL, Pardo-Morales RV, Martinez-Carrillo BE and
Harbige LS: Effect of n-3 polyunsaturated fatty acid
supplementation on metabolic and inflammatory biomarkers in type 2
diabetes mellitus patients. Nutrients. 9:E5732017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Catalan V, Gomez-Ambrosi J, Rodriguez A,
Salvador J and Fruhbeck G: Adipokines in the treatment of diabetes
mellitus and obesity. Expert Opin Pharmacother. 10:239–254. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Erdem G, Dogru T, Tasci I, Sonmez A and
Tapan S: Low plasma apelin levels in newly diagnosed type 2
diabetes mellitus. Exp Clin Endocrinol Diabetes. 116:289–292. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhu S, Sun F, Li W, Cao Y, Wang C, Wang Y,
Liang D, Zhang R, Zhang S, Wang H and Cao F: Apelin stimulates
glucose uptake through the PI3K/Akt pathway and improves insulin
resistance in 3T3-L1 adipocytes. Mol Cell Biochem. 353:305–313.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shen X, Zhou N, Mi L, Hu Z, Wang L, Liu X
and Zhang S: Phloretin exerts hypoglycemic effect in
streptozotocin-induced diabetic rats and improves insulin
resistance in vitro. Drug Des Devel Ther. 11:313–324. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Williams LJ, Nye BG and Wende AR:
Diabetes-related cardiac dysfunction. Endocrinol Metab (Seoul).
32:171–179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kang OH, Shon MY, Kong R, Seo YS, Zhou T,
Kim DY, Kim YS and Kwon DY: Anti-diabetic effect of black ginseng
extract by augmentation of AMPK protein activity and upregulation
of GLUT2 and GLUT4 expression in db/db mice. BMC Complement Altern
Med. 17:3412017. View Article : Google Scholar : PubMed/NCBI
|
